New Orleans, Louisiana Clinical Trials

A listing of New Orleans, Louisiana clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 39 clinical trials
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

headache
ly573144
migraine
preventive medication
lasmiditan
Children's Hospital of New Orleans LCMC Health
 (3.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +162 other locations
Study to Evaluate Patients With Cerebrotendinous Xanthomatosis

The study is made up of two cohorts: a randomized double-blind crossover (placebo withdrawal with rescue) study among patients 16 years of age (adult cohort) and an open-label dose titration study among pediatric patients 1 month and <16 years of age (pediatric cohort)

Retrophin Investigational Site
 (0.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

tumor markers
measurable disease
recurrent childhood medulloblastoma
recurrent thyroid gland carcinoma
nitrosoureas
Children's Hospital New Orleans
 (3.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +82 other locations
A Study to Evaluate NT219 Alone and in Combination With ERBITUX (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer

This is a phase 1/2, multi-center study with an open-label, dose escalation phase followed by a single-arm expansion phase to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of NT219 alone and in combination with ERBITUX (cetuximab) in adults with recurrent and/or metastatic solid tumors.

erbitux
gilbert's syndrome
brain metastasis
carcinoma
measurable disease
Ochsner Clinic Foundation
 (5.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidate at up to three dose levels in adult participants aged 18 to 45 years with moderate to severe acne. This trial will consist of a …

DelRicht Research - New Orleans 308- Site Number : 8400013
 (2.9 away) Contact site
  • 0 views
  • 29 Nov, 2025
  • +30 other locations
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The …

deficiency
imiglucerase
eliglustat
gaucher disease
Investigational Site Number 840001
 (0.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +220 other locations
Fabry Disease Registry & Pregnancy Sub-registry

The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The primary …

agalsidase beta
replacement therapy
fabry's disease
deficiency
fabrazyme
Investigational Site Number 840001
 (0.7 away) Contact site
  • 0 views
  • 05 Aug, 2024
  • +136 other locations
Pharmacokinetics Pharmacodynamics and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to …

SARS
acute respiratory syndrome (sars)
Tulane University Health Science Center
 (0.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +34 other locations
NCI COVID-19 in Cancer Patients NCCAPS Study

This study collects blood samples, medical information, and medical images from patients who are being treated for cancer and have a positive test for SARS CoV-2, the new coronavirus that causes the disease called COVID-19. Collecting blood samples, medical information, and medical images may help researchers determine how COVID-19 affects …

stem cell transplant
cellular therapy
targeted radionuclide therapy
stem cell transplantation
radiation therapy, targeted
Louisiana State University Health Science Center
 (0.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +575 other locations